ethyl pyruvate has been researched along with Lung Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, H; Imai, H; Kamada, Y; Kimura, A; Nishimori, R; Shimokawa, A; Stewart, NJ; Utsumi, S | 1 |
| Huo, Y; Jia, L; Liu, Q; Wang, P; Zhao, J; Zheng, H | 1 |
| Lehnert, M; Marzi, I; Meier, S; Omid, N; Oppermann, E; Perl, M; Relja, B; Schaible, A | 1 |
| Fei, G; Li, Q; Liu, Z; Ren, T; Wang, C; Xu, Z | 1 |
| Choi, JE; Duong, HQ; Han, SI; Jeong, GA; Kang, HS; Kim, CH; Lim, SC | 1 |
5 other study(ies) available for ethyl pyruvate and Lung Neoplasms
| Article | Year |
|---|---|
Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized
Topics: Animals; Carcinogens; Inflammation; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Pyruvates; Urethane; Xenon | 2021 |
Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway.
Topics: Antigens, Neoplasm; Apoptosis; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; NF-kappa B; Pyruvates; STAT3 Transcription Factor; Tumor Cells, Cultured | 2019 |
Pre- or post-treatment with ethanol and ethyl pyruvate results in distinct anti-inflammatory responses of human lung epithelial cells triggered by interleukin-6.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Survival; Enzyme-Linked Immunosorbent Assay; Ethanol; Gene Expression Regulation, Neoplastic; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Leukocytes, Mononuclear; Lung Neoplasms; Neutrophils; Pyruvates | 2015 |
HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 2; Gene Knockdown Techniques; HMGB1 Protein; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Targeted Therapy; Myeloid Differentiation Factor 88; Oligodeoxyribonucleotides; Pyruvates; Receptor for Advanced Glycation End Products; RNA Interference; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Toll-Like Receptor 9; Up-Regulation | 2012 |
Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Glucose; HMGB1 Protein; Humans; Inflammation; Lung Neoplasms; Necrosis; Pyruvates; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured | 2007 |